GlaxoSmithKline's total assets for Q3 2024 were £58.05B, a decrease of -0.03% from the previous quarter. GB:GSK total liabilities were £44.60B for the fiscal quarter, a 0.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.